Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Advanced Gastric Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04193553
What this trial is testing

Multicentre Placebo-controlled Double-blinded Phase II Study of Lenvatinib Efficacy in Patients With Locally Advanced or Metastatic GIST (Gastrointestinal Stromal Tumor) After Imatinib/Sunitinib Failure

Who this might be right for
Gastro Intestinal Stromal Tumour
Centre Leon Berard 77
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Not applicableLooking for participantsNCT06846996
What this trial is testing

Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China

Who this might be right for
HER2-positive Gastric CancerHER2-positive Gastroesophageal Junction
Daiichi Sankyo 260
Testing effectiveness (Phase 2)WithdrawnNCT01070290
What this trial is testing

ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy Regimen

Who this might be right for
Gastric Cancer
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Testing effectiveness (Phase 2)Study completedNCT00436241
What this trial is testing

Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer.

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 45
Large-scale testing (Phase 3)UnknownNCT02773524
What this trial is testing

Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer

Who this might be right for
Gastro-Oesophageal Cancer
Australasian Gastro-Intestinal Trials Group 250
Not applicableUnknownNCT04889768
What this trial is testing

HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Gastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and Surgery
Zhejiang Cancer Hospital 46
Early research (Phase 1)Ended earlyNCT04171141
What this trial is testing

Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

Who this might be right for
Gastrointestinal TumorsColorectal AdenocarcinomasGastric Adenocarcinomas+1 more
Pfizer 79
Testing effectiveness (Phase 2)Study completedNCT03941873
What this trial is testing

Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer

Who this might be right for
Carcinoma, HepatocellularGastric/Gastroesophageal Junction Cancer
BeiGene 111
Testing effectiveness (Phase 2)UnknownNCT03957564
What this trial is testing

Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer

Who this might be right for
Gastric CancerGastro-oesophageal Junction Cancer
Affiliated Hospital of Qinghai University 40
Testing effectiveness (Phase 2)Ended earlyNCT02999893
What this trial is testing

APR-246 in Oesophageal Cancer

Who this might be right for
Oesophageal Carcinoma
Peter MacCallum Cancer Centre, Australia 5
Not applicableUnknownNCT05720598
What this trial is testing

Staging LaParoscopy to Assess Lymph NOde InvoLvement in Advanced GAstric Cancer

Who this might be right for
Gastric CancerLymph Node Metastasis
Medical University of Lublin 190
Testing effectiveness (Phase 2)Ended earlyNCT04579757
What this trial is testing

Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors

Who this might be right for
Metastatic Solid TumorColorectal CancerNeuroendocrine Tumors+4 more
Hutchmed 87
Early research (Phase 1)Ended earlyNCT01705340
What this trial is testing

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionHER2-positive Breast CancerMale Breast Cancer+9 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00210184
What this trial is testing

Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer

Who this might be right for
Gastric Cancer
Institut Bergonié 42
Early research (Phase 1)Ended earlyNCT02908451
What this trial is testing

AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+1 more
AbGenomics B.V Taiwan Branch 39
Not applicableStudy completedNCT03528629
What this trial is testing

IMAB362 in Japanese Subjects With Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric CancerGastro-esophageal Junction (GEJ) Cancer
Astellas Pharma Inc 18
Large-scale testing (Phase 3)Study completedNCT00680901
What this trial is testing

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

Who this might be right for
Neoplasms, Gastrointestinal Tract
Novartis Pharmaceuticals 545
Testing effectiveness (Phase 2)Active Not RecruitingNCT07143604
What this trial is testing

Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
AstraZeneca 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446049
What this trial is testing

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

Who this might be right for
Locally Advanced or Metastatic Solid TumorsPTEN Loss or Low Expression
Convalife (Shanghai) Co., Ltd. 180
Next Page